Harry Veerman
Impact in
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
Papers in ⓘ
-
- Protease and Inhibitor Mechanisms 12
-
- Blood Coagulation and Thrombosis Mechanisms 6
- Co-authors
- Hans Pannekoek (12 shared papers)Anton Jan van Zonneveld (6 shared papers)Jan A. van Mourik (3 shared papers)C. de Vries (3 shared papers)C L Verweij (1 shared paper)Hans Lambers (2 shared papers)P.J. Diergaarde (2 shared papers)Piet Borst (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Thrombosis and Haemostasis (3 papers)Biochemistry (2 papers)Journal of Cellular Biochemistry (1 paper)The EMBO Journal (1 paper)
- Partner nations
- NetherlandsSwitzerlandItaly
In The Last Decade
Harry Veerman
13 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Hematology 644
- Cancer Research 847
- Immunology and Allergy 152
- Biotechnology 148
- Pulmonary and Respiratory Medicine 309
Countries citing papers authored by Harry Veerman
This map shows the geographic impact of Harry Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Veerman more than expected).
Fields of papers citing papers by Harry Veerman
This network shows the impact of papers produced by Harry Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Veerman. The network helps show where Harry Veerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry Veerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 293 | |
| 2 | 1986 | 202 | |
| 3 | 1986 | 195 | |
| 4 | 1984 | 136 | |
| 5 | 1987 | 93 | |
| 6 | 1989 | 80 | |
| 7 | 1986 | 75 | |
| 8 | 1989 | 59 | |
| 9 | 1988 | 39 | |
| 10 | 1987 | 39 | |
| 11 | 1990 | 30 | |
| 12 | 1991 | 9 | |
| 13 | 1986 | 3 | |
| 14 | 1987 | 1 |
About Harry Veerman
Harry Veerman is a scholar working on Cancer Research, Hematology, Pulmonary and Respiratory Medicine, Molecular Biology and Biotechnology, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (12 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Blood properties and coagulation (5 papers), Enzyme Production and Characterization (4 papers), Cancer-related gene regulation (2 papers), Peptidase Inhibition and Analysis (1 paper), Signaling Pathways in Disease (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Hematology (644 citations), Cancer Research (847 citations), Immunology and Allergy (152 citations), Biotechnology (148 citations) and Pulmonary and Respiratory Medicine (309 citations). Harry Veerman has collaborated with scholars based in Netherlands, Switzerland and Italy. Frequent co-authors include Hans Pannekoek, Anton Jan van Zonneveld, Jan A. van Mourik, C. de Vries, C L Verweij, Hans Lambers, P.J. Diergaarde, Piet Borst, Titia de Lange and Alberto C.C. Frasch. Their work appears in journals such as Journal of Biological Chemistry, Thrombosis and Haemostasis, Biochemistry, Journal of Cellular Biochemistry and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.